Status:

UNKNOWN

Early Mitral ValvE Repair Versus Watchful Waiting for Asymptomatic SEvere Degenerative Mitral Regurgitation

Lead Sponsor:

Centre Hospitalier Universitaire, Amiens

Conditions:

Degenerative Mitral Regurgitation (MR) Due to Leaflet Prolapse

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Degenerative mitral regurgitation (MR) due to leaflet prolapse is frequent and can be surgically repaired in the vast majority of patients. Despite the efficacy of mitral valve repair, an ongoing inte...

Detailed Description

Experimental group: In patients randomized to early mitral valve repair, surgery will be performed within 3 months after randomization. Clinical interview will be performed at discharge, at 6 months a...

Eligibility Criteria

Inclusion

  • Asymptomatic patients according history or an exercise test in those able to perform it if there is a doubt about the absence of symptoms
  • Severe (grade IV) degenerative MR due to leaflet prolapse assessed by echocardiography
  • LV ejection fraction by Simpson biplane method ≥60% and LV end-systolic diameter by TM echocardiography ≤40mm
  • Sinus rhythm on the inclusion ECG
  • Pulmonary artery pressure ≤50 mmHg by Doppler echocardiography.
  • High probability of mitral valve repair
  • EuroSCORE II ≤ 3%

Exclusion

  • Mitral stenosis or \> mild aortic valve disease (stenosis or regurgitation)
  • Congenital heart disease (except patent foramen ovale or atrial septal defect)
  • Patients with cardiac prostheses
  • Previous myocardial infarction
  • Previous cardiac surgery
  • Extra cardiac comorbidity with life expectancy \< 5 years
  • Recent history of psychiatric disease (including drug or alcohol abuse)
  • Therapy with an investigational intervention at the time of screening or plan to enrol patient in additional intervention study during participation in this trial

Key Trial Info

Start Date :

April 10 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2026

Estimated Enrollment :

424 Patients enrolled

Trial Details

Trial ID

NCT03389542

Start Date

April 10 2018

End Date

January 1 2026

Last Update

June 8 2018

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

CHU Amiens-Picardie

Amiens, France, 80054

2

Centre Cardiologique du Nord

Saint-Denis, France, 93200